NewsEuropeGerman Medical Cannabis Scripts Mainly For Pain

German Medical Cannabis Scripts Mainly For Pain

-

PAIN is most common ailment for which patients are prescribed medical cannabis, say the German Government 

The introduction of its medical cannabis programme in 2017 saw physicians allowed to prescribe medicinal cannabis for over 60 illnesses.

Almost three quarters of all prescriptions from a Government sample of over 6,500 are for pain – at 71%

This was followed by spasticity – a muscle condition at 11% – and anorexia at 7%, with epilepsy,  migraines, ADHD and Tourettes Syndrome all featuring, too.

The data is based on an ongoing government survey involving 6,538 patients, as of September last year, reports the Marijuana Business Daily website.

This survey on the medical market will run until March 2022 and will then be used determine the future of medical cannabis insurance coverage.

Germany’s medical cannabis programme began in March 2017, and 

‘The Germany Cannabis Report’  by  Prohibition Partners  estimates 60,000 patients have been helped.

One of the most pressing issues in the German market is that it does not have the supply chain to satiate demand and has consequently granted supply licenses to three Canadian, and one domestic, producer while it  encourages the development of a homegrown industry.

This comes an estimated four million Germans use cannabis, with 17% of 18 to 25-year-olds saying they had used it in the past 12 months.

Despite being illegal, the state will not usually prosecute anyone found to have six grams of cannabis, or less – a limit agreed by state interior ministers, in 2018.

https://mjbizdaily.com/new-data-reveals-to

Peter
Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

As Its Neighbours Seek Legalisation, Poland’s Medical Cannabis & Hemp Industry Could Also Flourish Next Year

EARLIER this month Czechia’s drug commissioner Jindřich Vobořil announced his intention to submit draft legislation for an adult-use cannabis...

German Prohibitionists Lobby EU, German Medical Cannabis Re-Think, High Court Blow For Irish CBD, Hemp Batteries In Electric Vehicles?

GERMAN opponents of its adult-use cannabis programme are taking their fight to Brussels in a bid to scupper the...

Akanda Pulls Out Of Lesotho Amid Ongoing Legal Battle, Bruce Linton Joins SynBiotic, & Ananda Completes Acquisition

Akanda The NASDAQ-listed international medical cannabis operator announced last week that it will abandon its operations in Lesotho following...

Concerns Grow As Cannabis Sceptic Appointed To Lead Malta’s Adult-Use Reform

ALMOST one year since passing legislation fears are growing the Maltese Government is set to undermine its commitment to...

Brains Bio Receives NSF’s First CBD Certification For EU GMP CBD API

PRESS RELEASE BRAINS Bioceutical Corp ("Brains Bio" or the "Company"), a global leader in EU GMP grade Cannabidiol (CBD) has...

Amsterdam Cannabis Expo 2022 Latest Scam To Target Industry

AN upcoming European cannabis conference, at which 10,000 cannabis companies were purportedly due to visit, is thought to be...

Must read

As Its Neighbours Seek Legalisation, Poland’s Medical Cannabis & Hemp Industry Could Also Flourish Next Year

EARLIER this month Czechia’s drug commissioner Jindřich Vobořil announced...

You might also likeRELATED
Recommended to you